Efficacy and safety of alogliptin in patients with type 2 diabetes mellitus: A multicentre randomized double-blind placebo-controlled Phase 3 study in mainland China, Taiwan, and Hong Kong. - Pan, Changyu; Han, Ping; Ji, Qiuhe; Li, Chengjiang; Lu, Juming; Yang, Jinkui; Li, Wenhui; Zeng, Jiaoe; Hsieh, An ‐ Tsz; Chan, Juliana (Journal of Diabetes, 2017)